Brigham and Women's Hospital
Boston, Massachusetts, 02115, United States
NCT Number: NCT01581125
The purpose of this study is to test the hypothesis that sleep and performance depend on length of time awake, length of time asleep, the amount of sleep over several sleep episodes, and circadian phase.
Looking for future studies?
Notify Me18 year–35 year
All sexes
Interventional
Not applicable
Boston, Massachusetts, 02115, United States
The purpose of this study is to test the hypothesis that sleep and performance depend on length of time awake, length of time asleep, the amount of sleep over several sleep episodes, and circadian phase. Inpatient sleep and performance data will be collected from healthy volunteers.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Sleep and Wake durations for arm 1
Sleep and Wake durations for arm2
Time frame: PVT during waking for arms 1 and 2 during the 32-day inpatient portion of the protocol
PVT metrics are reaction time. It is measured when the participants are awake during the inpatient portion of the protocol.
Brigham and Women's Hospital
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06180837
Behavior, Behavior, Animal
Salt Lake City, Utah, United States
View Trial DetailsNCT05026541
Cognitive Change, Dyssomnias
Boston, Massachusetts, United States
View Trial DetailsNCT04473222
Dyssomnias, Mental Disorders
Philadelphia, Pennsylvania, United States
View Trial DetailsNCT04279834
Apnea, Cardiovascular Diseases
Detroit, Michigan, United States
View Trial Details